Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Bayer
Woman Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
Multi-center, open-label, uncontrolled study to investigate the efficacy and safety of the transdermal contraceptive patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene (material no. 80876395) in a 21-day regimen for 13 cycles in 1650 healthy female subjects
The primary objective of this study is to investigate the contraceptive efficacy of the transdermal contraceptive patch (material no. 80876395).
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Bayer Consumer Care AG
Update Il y a 4 ans
A double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of acetylsalicylic acid combined with pseudoephedrine, compared with acetylsalicylic acid alone, and pseudoephedrine alone, on symptoms of pain and nasal congestion in patients with symptomatic upper respiratory tract infection
The primary objective is to compare the efficacy of 1000 mg ASA combined with 60 mg PSE for pain and nasal congestion with 1000 mg ASA alone, 60 mg PSE alone and placebo in subjects with symptomatic c...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Bayer AG
Update Il y a 4 ans
A study to evaluate the safety and efficacy of study drug radium-223 dichloride when given in combination with bortezomib and dexamethasone in patients with multiple myeloma that has recurred Ensayo para evaluar la seguridad y eficacia del dicloruro de radio-223 (BAY 88-8223) cuando es dado en combinación con bortezomib y dexametasona en el tratamiento del mieloma múltiple en recidiva precoz
Phase 1b part (open-label) 1. To evaluate the safety of the combination of radium-223 dichloride plus bortezomib and dexamethasone 2. To determine the dose of radium-223 dichloride that will be u...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
BAY94-8862 dose finding trial in subjects with chronic heart failure and mild (Part A) or moderate (Part B) chronic kidney disease
Part A The safety and tolerability of 3 oral doses of BAY 94 8862 given once daily over 4 weeks in a randomized, placebo-controleld, double-blind study in subjects with chronic heart failure (CHF) wit...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Bayer AG
Update Il y a 4 ans
Vision loss diagnosed as a Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
To determine whether the use of PDE5 inhibitors (vardenafil, sildenafil, tadalafil or avanafil) increases the risk for the development of NAION.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Bayer HealthCare
Update Il y a 4 ans
Etude CHRONOS-4 : étude randomisée de phase 3 visant à comparer le copanlisib en association avec une immunothérapie et une chimiothérapie standard à une immunothérapie et chimiothérapie standard seule chez des patients ayant un lymphome non hodgkinien indolent en rechute.
Le lymphome non hodgkinien (NHL) est un cancer qui prend naissance dans les lymphocytes qui sont des cellules du système lymphatique constituant une des lignées de défense de l’organisme contre les ma...
Country
France
organs
Lymphomes non hodgkinien
Specialty
Chimiothérapie
,
Thérapies Ciblées
,
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Bayer Schering Pharma AG (Germany)
Update Il y a 4 ans
Myocardial perfusion with an intravascular contrast agent
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Bayer HealthCare AG
Update Il y a 4 ans
A study investigating the safety of radium-223 dichloride with abiraterone acetate and prednisone/prednisolone given to patients with castration-resistant prostate cancer that has spread to bone, and who never had chemotherapy before
The primary objective is to compare the clinical benefit of radium-223 dichloride versus placebo in combination with abiraterone and prednisone/prednisolone in asymptomatic or mildly symptomatic chem...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Bayer
Update Il y a 4 ans
CORRECT : Essai de phase 3 randomisé en double aveugle comparant l’efficacité d’un traitement symptomatique optimal associé ou non à du régorafénib, chez des patients ayant un cancer colorectal métastatique en progression. [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer l’apport du régorafénib à un traitement symptomatique optimal, chez des patients ayant un cancer colorectal métastatique en progression après un traitement standa...
Country
France
organs
Côlon ou Rectum (colorectal)
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman Max 99 years
Bayer Schering Pharma AG
Update Il y a 4 ans
Multi-center, open, randomized, dose finding phase II study to investigate for a maximum of three years ultra low dose levonorgestrel contraceptive intrauterine systems (LCS) releasing in vitro 12 µg/24 h and 16 µg/24 h of levonorgestrel compared to MIRENA in nulliparous and parous women in need of contraception
The objective of this study is to search for an appropriate levonorgestrel dose for a new contraceptive intrauterine system (IUS) suitable for use by non-parous and parous women.
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
4
5
6
7
8
9
10
11
12
13
Next